Chemical Composition of JUUL Pods Collected From Students in California High Schools.

Adolescent Curriculum Electronic nicotine Delivery Systems Nicotine Schools Students Tobacco

Journal

The Journal of adolescent health : official publication of the Society for Adolescent Medicine
ISSN: 1879-1972
Titre abrégé: J Adolesc Health
Pays: United States
ID NLM: 9102136

Informations de publication

Date de publication:
08 2021
Historique:
received: 01 07 2020
revised: 24 11 2020
accepted: 24 11 2020
pubmed: 14 3 2021
medline: 7 8 2021
entrez: 13 3 2021
Statut: ppublish

Résumé

To examine the chemical composition of JUUL pods collected from a convenience sample of 16 high schools in California to identify possible consumer modification or counterfeit use. Using Gas Chromatography-Mass Spectrometry, we quantitatively analyzed the nicotine, propylene glycol (PG), and vegetable glycerin (VG) in JUUL pods (n = 26) collected from California high schools and compared results to commercial 3% (n = 15) and 5% (n = 24) JUUL pods purchased online. Most of the collected JUUL pods (24/26 pods) had a nicotine concentration (43.3 mg/ml, 95% PI: 21.5-65.1) outside the prediction intervals (PI) of the 3% (33.5 mg/ml, 95% PI: 31.8-35.2) and 5% (55.0 mg/ml, 95% PI: 51.5-58.3) commercial JUUL pods. Most (73%) collected JUUL pods had VG concentrations (583.5 mg/ml, PI: 428.9-738.1) lower than the 3% (722.2 mg/ml, PI: 643.0-801.4) and 5% (710.5 mg/ml, PI: 653.1-767.8) commercial JUUL pods. Used JUUL products collected from high school students or found on school grounds were not chemically consistent with the manufacturer's stated formulations.

Identifiants

pubmed: 33712386
pii: S1054-139X(20)30692-3
doi: 10.1016/j.jadohealth.2020.11.023
pii:
doi:

Substances chimiques

Flavoring Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

342-345

Informations de copyright

Published by Elsevier Inc.

Auteurs

Mays Shamout (M)

Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia; Epidemic Intelligence Service, Division of Scientific Education and Professional Development, Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia. Electronic address: olv6@cdc.gov.

Ping Wang (P)

Indoor Air Quality Program, California Department of Public Health, Richmond, California.

Flavia Wong (F)

Indoor Air Quality Program, California Department of Public Health, Richmond, California.

Wenhao Chen (W)

Indoor Air Quality Program, California Department of Public Health, Richmond, California.

Kazukiyo Kumagai (K)

Indoor Air Quality Program, California Department of Public Health, Richmond, California.

José J Pérez (JJ)

Tobacco and Volatiles Branch, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia.

Clifford H Watson (CH)

Tobacco and Volatiles Branch, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia.

Liza Valentín-Blasini (L)

Tobacco and Volatiles Branch, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia.

Lauren Tanz (L)

Epidemic Intelligence Service, Division of Scientific Education and Professional Development, Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia.

Carolyn Herzig (C)

Epidemic Intelligence Service, Division of Scientific Education and Professional Development, Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia.

Lisa P Oakley (LP)

Epidemic Intelligence Service, Division of Scientific Education and Professional Development, Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia.

Corey M Peak (CM)

Epidemic Intelligence Service, Division of Scientific Education and Professional Development, Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia.

Amy Heinzerling (A)

Epidemic Intelligence Service, Division of Scientific Education and Professional Development, Center for Surveillance, Epidemiology, and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia.

Rebecca J Williams (RJ)

California Tobacco Control Program, California Department of Public Health, Sacramento, California.

Catherine Hess (C)

California Tobacco Control Program, California Department of Public Health, Sacramento, California; Institute for Population Health Improvement, University of California Davis Health System, Sacramento, California.

Chunxia Wang (C)

Tobacco-Use Prevention Education Office, California Department of Education, Sacramento, California.

Sarah Planche (S)

Tobacco-Use Prevention Education Office, California Department of Education, Sacramento, California.

Maeh Al-Shawaf (M)

Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.

Paul Melstrom (P)

Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.

Kristy Marynak (K)

Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.

Michael A Tynan (MA)

Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.

Israel T Agaku (IT)

Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.

Brian A King (BA)

Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH